跳至主要内容
临床试验/IRCT2013121215765N1
IRCT2013121215765N1已完成2 期

Metformin and placebo effects on TSH and thyroid volume in patients with pre-diabetes

Isfahan Endocrine and Metabolism Research Center0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inclusion criteria :patients with pre-diabetes [Impaired fasting plasma glucose (100 to 125 mg/dl) or impaired glucose tolerance (IGT) (2-h PG OGTT values of 140–199 mg/dL and having 18 to 65 years old] were initially included.
  • Exclusion criteria:
  • Those patients with thyroid malignancy or any other malignancy; previous-thyroxin suppression therapy at any time; obesity due to endocrine disease; Pregnancy and lactation; renal failure or liver failure; neurological or psychological disorders (depression, epilepsy, schizophrenia); heart failure; hypothyroidism or hyperthyroidism; smoking and finally iodinated contrast material exposure in the previous 6 months ago all were excluded from the study.

排除标准

  • 未提供

研究者

发起方
Isfahan Endocrine and Metabolism Research Center

相似试验